Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nicholson

Showing results (321-330 of 953) with videos related to

Pageof 96
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1996
Quantitative structure-metabolism relationships for substituted benzoic acids in the rabbit: prediction of urinary excretion of glycine and glucuronide conjugatesB C Cupid, C R Beddell, J C Lindon, et al.
Journal of Proteome Research|September 3, 2010
Dietary modulation of gut functional ecology studied by fecal metabonomicsFrancois-Pierre J Martin, Norbert Sprenger, Ivan Montoliu, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 20, 1998
750 MHz HPLC-NMR spectroscopic identification of rat microsomal metabolites of phenoxypyridinesO Corcoran, M Spraul, M Hofmann, et al.
Archives of Toxicology|January 1, 1992
Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damageM L Anthony, K P Gartland, C R Beddell, et al.
Biochemical Pharmacology|July 22, 1992
Studies on the biochemical effects of the aldose reductase inhibitor 2,7-difluorospirofluorene-9,5'-imidazolidine-2',4'-dione (Al 1576, HOE 843). Detection of D-glucaric and D-glucuronic acid excretion by high resolution 1H and 13C NMR spectroscopyV R Hoyle, P J Gilbert, J A Troke, et al.
Molecular Pharmacology|July 1, 1994
Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urineM L Anthony, B C Sweatman, C R Beddell, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1993
Deuterium NMR spectroscopy of biofluids for the identification of drug metabolites: application to N,N-dimethylformamideR D Farrant, S R Salman, J C Lindon, et al.
Diabetes Care|October 27, 2006
Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities StudyWanda K Nicholson, Keiko Asao, Frederick Brancati, et al.
Cardiovascular and Interventional Radiology|September 18, 2008
Pain levels within 24 hours after UFE: a comparison of morphine and fentanyl patient-controlled analgesiaHyun S Kim, Gregory J Czuczman, Wanda K Nicholson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Cytofluorometric analyses of human T cell CD2/CD4 inter-molecular interactionsC E Bueso-Ramos, R M Donahoe, J K Nicholson, et al.
Pageof 96

Showing results (321-330 of 953) with videos related to

Sort By:
Pageof 96
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1996
Quantitative structure-metabolism relationships for substituted benzoic acids in the rabbit: prediction of urinary excretion of glycine and glucuronide conjugatesB C Cupid, C R Beddell, J C Lindon, et al.
Journal of Proteome Research|September 3, 2010
Dietary modulation of gut functional ecology studied by fecal metabonomicsFrancois-Pierre J Martin, Norbert Sprenger, Ivan Montoliu, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 20, 1998
750 MHz HPLC-NMR spectroscopic identification of rat microsomal metabolites of phenoxypyridinesO Corcoran, M Spraul, M Hofmann, et al.
Archives of Toxicology|January 1, 1992
Cephaloridine-induced nephrotoxicity in the Fischer 344 rat: proton NMR spectroscopic studies of urine and plasma in relation to conventional clinical chemical and histopathological assessments of nephronal damageM L Anthony, K P Gartland, C R Beddell, et al.
Biochemical Pharmacology|July 22, 1992
Studies on the biochemical effects of the aldose reductase inhibitor 2,7-difluorospirofluorene-9,5'-imidazolidine-2',4'-dione (Al 1576, HOE 843). Detection of D-glucaric and D-glucuronic acid excretion by high resolution 1H and 13C NMR spectroscopyV R Hoyle, P J Gilbert, J A Troke, et al.
Molecular Pharmacology|July 1, 1994
Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urineM L Anthony, B C Sweatman, C R Beddell, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1993
Deuterium NMR spectroscopy of biofluids for the identification of drug metabolites: application to N,N-dimethylformamideR D Farrant, S R Salman, J C Lindon, et al.
Diabetes Care|October 27, 2006
Parity and risk of type 2 diabetes: the Atherosclerosis Risk in Communities StudyWanda K Nicholson, Keiko Asao, Frederick Brancati, et al.
Cardiovascular and Interventional Radiology|September 18, 2008
Pain levels within 24 hours after UFE: a comparison of morphine and fentanyl patient-controlled analgesiaHyun S Kim, Gregory J Czuczman, Wanda K Nicholson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1988
Cytofluorometric analyses of human T cell CD2/CD4 inter-molecular interactionsC E Bueso-Ramos, R M Donahoe, J K Nicholson, et al.
Pageof 96